Vendor, Durham, NC
Radiant DX Inc.
UEI U6TJRX9B3FX5, CAGE 9NJU1
1 award and -$54,753 obligated between September 8, 2026 and September 8, 2026, 100% under full and open competition, against 55.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | -$54,753 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91025C00043Definitive Contract, September 8, 2026, Full and Open Competition After Exclusion of Sources, 55 offers | NIH NCINational Institutes of Health | Claritas: Phenotypic and Multi-Omic Readouts to Inform Rare Cancer Combination TherapyNAICS 541714, PSC AN12 | -$54,753 |
- Places of performance
- North Carolina
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards